A re-closable wound dressing is provided. A base layer is operable to be attached to a skin of a patient. The base layer forms a pre-fabricated aperture through which a wound of the patient is accessible. A cover layer is coupled with the base layer. The cover layer is operable to cover the pre-fabricated aperture, and is permanently adhered to the base layer along at least a portion of the cover layer. The base layer and the cover layer are made of like materials.

An antimicrobial light dressing device, system and method for a percutaneous treatment that bathes a treatment region around the percutaneous insertion with an antibacterial illumination source for preventing pathogens around the insertion from entering via the dermal puncture created by the insertion. The antimicrobial light dressing device combines a circumferential body centered around the insertion, and an arrangement of LEDs around the body that focus the light around the insertion and onto a therapeutic region of the insertion. An opening in the circumferential body has an articulated protrusion for offsetting a medicinal vessel such as an IV tube off the skin surface to avoid blocking light to an area under the vessel.

The present invention pertains to an integrated wound dressing device for treatment of an insertion site of percutaneous and drug delivery devices. The integrated wound dressing device preferably comprises a transparent film layer having a bottom side, a top side and a perimeter. The bottom side is coated with an adhesive impregnated with an antimicrobial agent. The transparent film has a radius cutout between a central opening and the perimeter. A liquid crystal temperature sensitive film with an adhesive placed on the top side of the transparent film layer is preferably near and around the central opening. The dressing also has a layer of double folded release paper below the bottom side of the transparent film layer. The preferred TLCs used are cholesteryl esters with a preferable temperature detection range of 35-40° C. The preferred antimicrobial agent is chlorohexidine gluconate (CHG).

A method for manufacturing a medical tape includes: applying a solution polymer serving as an elastic base member portion having an elastic function to an upper layer of a film forming base portion having an inelastic function to form a film of the solution polymer; laminating an adhesion portion having a function to apply and hold the elastic base member portion to a skin on an upper layer of the elastic base member portion, and laminating a release portion having a function to protect the adhesion portion on an upper layer of the adhesion portion; peeling and removing the film forming base portion from the elastic base member portion to obtain the elastic base member portion in a state where a residual shrink force generated by a forming shrinkage of the solution polymer is reduced and to obtain a three-layer structure consisting of the elastic base member portion.

A reduced-pressure system for treating a tissue site on a patient includes a distribution manifold that adheres to a tissue site to allow retention without external support. The distribution manifold includes a porous member and a tissue-fixation element. The tissue-fixation element maintains the porous member substantially adjacent to the tissue site while a sealing member is applied. In one instance, the tissue-fixation element is a soluble adhesive that partially covers either the tissue-facing side of the porous member or a tissue-facing side of a fluid-permeable substrate layer that is on the tissue-facing side of the porous member. Other systems, distributions manifolds, and methods are presented.

An adhesive bandage system features a first member with an aperture substantially circumscribed by an adhesive layer couplable to a patient's skin. A second member of the adhesive bandage is removably couplable to the first member, having an adhesive along an outer perimeter on a first side, the outer perimeter sized so as to overlap with the first member. In some methods of use, a user may adhere the first member to a patient skin, administer a topical medication through the aperture, and then adhere the second member so as to cover the aperture. The second member may be removed, as needed, to either add medication, replace the medication with a new medication, or to have access to an injection site with a needle or catheter.

A multilayered wound dressing which is two-dimensional and has a peripheral edge is provided that includes at least one hydrophobic antimicrobial layer, at least one absorbent layer which includes a water-containing hydrogel, and a covering layer. Starting from the edge of the wound dressing, at least one incision is formed, which partially separates the wound dressing.

A medical wetness sensing device includes a base adapted to be disposed on a wearer of the medical wetness sensing device. The base includes a first electrical conductor and a second electrical conductor electrically insulated from the first electrical conductor. The first electrical conductor includes a hinge portion enabling a first portion of the first electrical conductor to deflect, at the hinge portion, relative to a second portion of the first electrical conductor. The medical wetness sensing device includes a controller electrically connected to the first electrical conductor and the second electrical conductor. The controller is configured to detect a presence or an absence of a medical fluid electrically connecting the first and second electrical conductors.

The invention relates to a plaster for use in the context of an intramuscular injection, particularly a vaccination, having a patient side and an outer side, comprising: an adhesive layer on the patient side for attaching the plaster to the skin of a patient, an absorbent wound-covering on the patient side in the region of an intended intramuscular injection site, the absorbent wound-covering having received a disinfectant, and an opening on the outer side in the area of the absorbent wound-covering of the patient side for the injection needle.

A closed-circuit dressing system for preventing moisture contacting PICC sites is provided. The closed-circuit dressing system include a breathable bag for harboring the PICC line(s) and a dressing film that envelopes the PICC site, wherein a moisture indicator ring provided by the dressing film indicates moisture penetrating a dressing reinforcement along the periphery of the dressing film.